JP2025506322A5 - - Google Patents

Info

Publication number
JP2025506322A5
JP2025506322A5 JP2024532528A JP2024532528A JP2025506322A5 JP 2025506322 A5 JP2025506322 A5 JP 2025506322A5 JP 2024532528 A JP2024532528 A JP 2024532528A JP 2024532528 A JP2024532528 A JP 2024532528A JP 2025506322 A5 JP2025506322 A5 JP 2025506322A5
Authority
JP
Japan
Prior art keywords
mother solution
concentration
range
salt
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024532528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506322A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2023/050982 external-priority patent/WO2023148680A1/en
Publication of JP2025506322A publication Critical patent/JP2025506322A/ja
Publication of JP2025506322A5 publication Critical patent/JP2025506322A5/ja
Pending legal-status Critical Current

Links

JP2024532528A 2022-02-04 2023-02-03 放射性核種錯体の大規模合成のための方法 Pending JP2025506322A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263306822P 2022-02-04 2022-02-04
US63/306,822 2022-02-04
PCT/IB2023/050982 WO2023148680A1 (en) 2022-02-04 2023-02-03 Methods for large scale synthesis of radionuclide complexes

Publications (2)

Publication Number Publication Date
JP2025506322A JP2025506322A (ja) 2025-03-11
JP2025506322A5 true JP2025506322A5 (cg-RX-API-DMAC7.html) 2025-12-26

Family

ID=85221934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532528A Pending JP2025506322A (ja) 2022-02-04 2023-02-03 放射性核種錯体の大規模合成のための方法

Country Status (9)

Country Link
US (1) US20260053959A1 (cg-RX-API-DMAC7.html)
EP (1) EP4472678A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506322A (cg-RX-API-DMAC7.html)
KR (1) KR20240146015A (cg-RX-API-DMAC7.html)
CN (1) CN118159303A (cg-RX-API-DMAC7.html)
CA (1) CA3235923A1 (cg-RX-API-DMAC7.html)
IL (1) IL313964A (cg-RX-API-DMAC7.html)
TW (1) TW202342112A (cg-RX-API-DMAC7.html)
WO (1) WO2023148680A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024317528A1 (en) * 2023-07-31 2026-03-05 Curium Us Llc [177 lu] lutetium-psma it composition and dosimetry, kit, method of making, and method of using thereof
WO2025210599A2 (en) 2024-04-05 2025-10-09 Novartis Ag Combination therapies with dna damage response inhibitors and [ 177lu]lu-psma-617
WO2026088112A1 (en) 2024-10-23 2026-04-30 Novartis Ag Combination therapies with ar-degrading agents and psma-targeting radioligands
WO2026099626A1 (en) 2024-11-08 2026-05-15 Novartis Ag Methods and systems for manufacturing radiopharmaceuticals
WO2026120497A1 (en) 2024-12-05 2026-06-11 Novartis Ag Stable radionuclide complex solutions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7358451B2 (ja) * 2018-07-25 2023-10-10 アドバンスド アクセラレーター アプリケーションズ 安定な濃厚放射性核種錯体溶液
IL280314B1 (en) * 2018-07-25 2026-07-01 Advanced Accelerator Applications Sa Stable and concentrated radionuclide complex solutions
WO2020079799A1 (ja) 2018-10-18 2020-04-23 三菱電機株式会社 付加製造加工機および冷却方法
CN112969675B (zh) * 2018-10-31 2024-12-20 意大利国际先进加速器应用有限公司 用于合成放射性核素络合物的方法
MX2021015467A (es) * 2019-06-14 2022-01-24 Edinburgh Molecular Imaging Ltd Compuestos y metodos de uso.

Similar Documents

Publication Publication Date Title
CN112969675B (zh) 用于合成放射性核素络合物的方法
CN103889930B (zh) 用于制备68Ga络合物的工艺
JP2023552180A5 (cg-RX-API-DMAC7.html)
CN107261159A (zh) 使用抗坏血酸稳定化放射性药物组合物
Eersels et al. Manufacturing I‐123‐labelled radiopharmaceuticals. pitfalls and solutions
JP2023117417A5 (cg-RX-API-DMAC7.html)
JP2025111424A5 (cg-RX-API-DMAC7.html)
CN118159303A (zh) 用于大规模合成放射性核素络合物的方法
EP3503929B1 (en) Rapid isolation of cyclotron-produced gallium-68
JP2009229201A (ja) Gaのイオンを単離する方法とそのための装置
WO2011033120A2 (en) Method for obtaining 68ga
JP2015500865A (ja) クエン酸緩衝液中の18f−フルシクロビン組成物
KR100555298B1 (ko) 테크네튬-안티모니 설파이드 나노콜로이드의 제조방법
Jeong et al. Synthesis of no‐carrier‐added [18F] fluoroacetate
US8337810B2 (en) Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters
Satpati et al. Comparative evaluation of [99mTc (H2O) 3 (CO) 3]+ precursor synthesized by conventional method and by using carbonyl kit
CN110582494A (zh) 碘氟潘的制造方法
CN117500525A (zh) pH调节的抗坏血酸溶液的制备
WO2005014479A2 (en) Process for preparing radiolabeled compounds
JP2001501616A (ja) レニウム又はテクネチウムの酸素化化合物を還元する方法
KR102207372B1 (ko) 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물
RU2464043C1 (ru) СПОСОБ ПОЛУЧЕНИЯ РАСТВОРОВ 68Ga ВЫСОКОЙ ЧИСТОТЫ
Eerselsa et al. Manufacturing of I-123-labelled radiopharmaceuticals
CN116585888A (zh) 一种基于140Nd-140Pr发生器分离140Pr的方法
Park et al. Synthesis and characterization of 99mTc‐labelled biologically active molecules using borohydride exchange resin as a reducing agent for the preparation of radiopharmaceuticals